Intraperitoneal Chemotherapy for Epithelial Ovarian Cancer – Single Center Experience
نویسندگان
چکیده
منابع مشابه
Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy
PURPOSE Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been proposed for controlling peritoneal seeding metastasis in some kinds of cancers, including those of colorectal origin, but their safety and oncological benefits are subjects of debate. We present our early experience with those procedures. METHODS Data were retrospectively collected from all pa...
متن کاملIntraperitoneal chemotherapy for ovarian cancer.
Vol. 39, No. 4, July 2012 • Oncology Nursing Forum O varian cancer remains an uncommon cancer compared to other female malignancies, such as breast, lung, and colon cancer. However, ovarian cancer is the leading cause of death among all gynecologic malignancies and the second most prevalent of the reproductive cancers (Siegel, Naishadham, & Jemal, 2012). According to the National Comprehensive ...
متن کاملIntraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
OBJECTIVE To assess retrospectively the feasibility of intraoperative intraperitoneal (IP) chemotherapy with cisplatin in epithelial ovarian cancer. METHODS IP chemotherapy during optimal staging surgery was performed in 10 patients who were diagnosed with primary epithelial ovarian cancers between April 2008 and February 2011. Cisplatin (70 mg/m(2) in 1 L normal saline solution) was administ...
متن کاملTreatment of Ovarian Cancer With Intraperitoneal Chemotherapy
In early 2006, the National Cancer Institute (NCI) issued a Clinical Announcement suggesting that intraperitoneal (IP) chemotherapy should become the standard of care for patients with newly diagnosed stage III optimally debulked epithelial ovarian cancer. IP chemotherapy, the administration of chemotherapy or biologic therapy via catheter into the peritoneal space, is new to many healthcare pr...
متن کاملIntraperitoneal chemotherapy: implications beyond ovarian cancer.
The National Cancer Institute (NCI) announced in January 2006 the use of intraperitoneal (IP) combined with IV chemotherapy postoperatively as the preferred treatment method for advanced ovarian cancer. The announcement stimulated the need for oncology nurses to become familiar with IP chemotherapy administration and patient management guidelines. IP administration allows a high concentration o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Surgical Oncology
سال: 2012
ISSN: 0975-7651,0976-6952
DOI: 10.1007/s13193-012-0166-y